Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).

scientific article

Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA). is …
instance of (P31):
scholarly articleQ13442814
MDMAQ69488

External links are
P356DOI10.1021/JM00109A020
P698PubMed publication ID1674539
P5875ResearchGate publication ID21480303

P2093author name stringJohnson MP
Nichols DE
Oberlender R
Frescas SP
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1662-1668
P577publication date1991-05-01
P1433published inJournal of Medicinal ChemistryQ900316
P1476titleSynthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).
P478volume34

Reverse relations

cites work (P2860)
Q925757062-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors
Q414039714-Methyl-3-nitro-benzaldehyde
Q31911068Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus
Q34199734Aminoindanes--the next wave of 'legal highs'?
Q33905588An analysis of legal highs: do they contain what it says on the tin?
Q34749393Arylethylamine psychotropic recreational drugs: a chemical perspective.
Q33869570Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action
Q44499276Homolytic cleavages in pyridinium ions, an excited state process
Q34461106Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential
Q28239102Initial characterization of PMMA as a discriminative stimulus
Q42395888Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents
Q38123776MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update
Q30251771Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
Q34607458Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue
Q34117810Serotonin releasing agents. Neurochemical, therapeutic and adverse effects
Q43921571Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release
Q47567624Synthetic Aminoindanes: A Summary of Existing Knowledge.
Q34476946The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats
Q48655807The effect of N-methylation on fenfluramine's neurotoxic and pharmacologic actions
Q34142899Therapeutic and adverse actions of serotonin transporter substrates

Search more.